(32)P in the treatment of myeloproliferative disorders.

Lawless, Sarah; McMullin, Mary Frances; Cuthbert, Robert; Houston, Russell

Lawless, Sarah; McMullin, Mary Frances; Cuthbert, Robert; Houston, Russell.

Affiliation

Lawless S; Department of Haematology, Belfast City Hospital, Belfast N. Ireland.
McMullin MF; Department of Haematology, Belfast City Hospital, Belfast N. Ireland; Queen's University Belfast, N. Ireland; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, N. Ireland.
Cuthbert R; Department of Haematology, Belfast City Hospital, Belfast N. Ireland.
Houston R; Department of Haematology, Belfast City Hospital, Belfast N. Ireland; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, N. Ireland.

Ulster Med J ; 85(2): 83-5, 2016 May.

Article in En | MEDLINE | ID: mdl-27601760

Subject(s)

Myeloproliferative Disorders; Phosphorus Radioisotopes/therapeutic use; Aged; Aged, 80 and over; Blood Cell Count/methods; Female; Humans; Ireland/epidemiology; Male; Medical Records, Problem-Oriented; Myeloproliferative Disorders/diagnosis; Myeloproliferative Disorders/epidemiology; Myeloproliferative Disorders/therapy; Outcome and Process Assessment, Health Care; Retrospective Studies

Key words

Essential Thrombocythemia; Polycythemia rubra vera; Radioactive phosphorous

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Phosphorus Radioisotopes / Myeloproliferative Disorders Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: Europa Language: En Journal: Ulster Med J Year: 2016 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google